If you have any question, please feel free to email us. We will touch with you as soon as possible.
CIMDUO (lamivudine and tenofovir disoproxil fumarate) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg. For R&D purposes only.
* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.
| Generic name | Lamivudine and Tenofovir Disoproxil Fumarate Tablets |
| Trade name | Cimduo |
| Specification | 300 mg of lamivudine and 300 mg of tenofovir disoproxil fumarate |
| Main ingredients | Lamivudine and Tenofovir Disoproxil Fumarate |
| Dosage Form | Tablet |
| MA Holder | Mylan Laboratories Ltd |
| Category | Reference Listed Drugs (RLDs) |
Indications:
CIMDUO (lamivudine and tenofovir disoproxil fumarate) is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 35 kg.
For more details, pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: lamivudine and tenofovir disoproxil fumarate tablets reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Agomelatine Tablets, Acarbose Tablets, Argatroban Injection, Alfacalcidol Soft Capsules, Bimatoprost Ophthalmic, Adefovir Dipivoxil Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
